Literature DB >> 1698441

Retrovirus mediated transfer and expression of GM-CSF in haematopoietic cells.

W N Keith1, R Brown, I B Pragnell.   

Abstract

Two retrovirus vectors were compared for their ability to express granulocyte-macrophage colony stimulating factor (GM-CSF) in a haematopoietic cell line, FDCP1, which is dependent on GM-CSF for survival. Both a MoMLV-based vector pVneoGM, and a MPSV-based vector, M3neoGM, were found to be capable of transmitting and expressing both GM-CSF and neomycin sequences in the myeloid FDCP1 cell line. Our results also demonstrate that pVneoGM is more efficient at generating GM-CSF independent colonies than M3neoGM. Analysis of cell lines derived after infection confirmed pVneoGM expressed higher levels of GM-CSF. Cell lines generated by infection with pVneoGM responded to levels of exogenous recombinant GM-CSF which did not stimulate growth of the parental cell line, suggesting autocrine stimulation may convey a proliferative advantage under sub-optimal growth conditions. Finally the parental vectors pVneo and M3neo were shown to be capable of expressing the neomycin gene in both murine haematopoietic progenitor and stem cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1698441      PMCID: PMC1971443          DOI: 10.1038/bjc.1990.304

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Hematopoietic growth factors.

Authors:  C A Sieff
Journal:  J Clin Invest       Date:  1987-06       Impact factor: 14.808

2.  Long terminal repeat sequences impart hematopoietic transformation properties to the myeloproliferative sarcoma virus.

Authors:  C Stocking; R Kollek; U Bergholz; W Ostertag
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

3.  Modulation of gene expression in multiple hematopoietic cell lineages following retroviral vector gene transfer.

Authors:  M C Magli; J E Dick; D Huszar; A Bernstein; R A Phillips
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

4.  The effect of stem cell proliferation regulators demonstrated with an in vitro assay.

Authors:  I B Pragnell; E G Wright; S A Lorimore; J Adam; M Rosendaal; J F DeLamarter; M Freshney; L Eckmann; A Sproul; N Wilkie
Journal:  Blood       Date:  1988-07       Impact factor: 22.113

5.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

6.  Developmental potential and dynamic behavior of hematopoietic stem cells.

Authors:  I R Lemischka; D H Raulet; R C Mulligan
Journal:  Cell       Date:  1986-06-20       Impact factor: 41.582

7.  Direct stimulation by purified GM-CSF of the proliferation of multipotential and erythroid precursor cells.

Authors:  D Metcalf; G R Johnson; A W Burgess
Journal:  Blood       Date:  1980-01       Impact factor: 22.113

8.  Point mutations in the U3 region of the long terminal repeat of Moloney murine leukemia virus determine disease specificity of the myeloproliferative sarcoma virus.

Authors:  C Stocking; R Kollek; U Bergholz; W Ostertag
Journal:  Virology       Date:  1986-08       Impact factor: 3.616

9.  Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses.

Authors:  R S McIvor; M J Johnson; A D Miller; S Pitts; S R Williams; D Valerio; D W Martin; I M Verma
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.

Authors:  R D Cone; R C Mulligan
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

View more
  1 in total

1.  An internal deletion enhances the transcriptional activity of a recombinant retrovirus in hematopoietic cells in vivo.

Authors:  K L MacKenzie; L Bonham; G Symonds
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.